372 related articles for article (PubMed ID: 22801410)
1. Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion.
Ma TM; Abazyan S; Abazyan B; Nomura J; Yang C; Seshadri S; Sawa A; Snyder SH; Pletnikov MV
Mol Psychiatry; 2013 May; 18(5):557-67. PubMed ID: 22801410
[TBL] [Abstract][Full Text] [Related]
2. Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.
Jacobi AA; Halawani S; Lynch DR; Lin H
Neurosci Lett; 2019 Jan; 692():107-114. PubMed ID: 30391323
[TBL] [Abstract][Full Text] [Related]
3. DISC1 in Astrocytes Influences Adult Neurogenesis and Hippocampus-Dependent Behaviors in Mice.
Terrillion CE; Abazyan B; Yang Z; Crawford J; Shevelkin AV; Jouroukhin Y; Yoo KH; Cho CH; Roychaudhuri R; Snyder SH; Jang MH; Pletnikov MV
Neuropsychopharmacology; 2017 Oct; 42(11):2242-2251. PubMed ID: 28631721
[TBL] [Abstract][Full Text] [Related]
4. Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism.
Abazyan S; Yang EJ; Abazyan B; Xia M; Yang C; Rojas C; Slusher B; Sattler R; Pletnikov M
J Neurosci Res; 2014 Dec; 92(12):1659-68. PubMed ID: 25131692
[TBL] [Abstract][Full Text] [Related]
5. DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disorders.
Xia M; Zhu S; Shevelkin A; Ross CA; Pletnikov M
J Neurochem; 2016 Aug; 138(4):518-24. PubMed ID: 27187935
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders.
Ayhan Y; Abazyan B; Nomura J; Kim R; Ladenheim B; Krasnova IN; Sawa A; Margolis RL; Cadet JL; Mori S; Vogel MW; Ross CA; Pletnikov MV
Mol Psychiatry; 2011 Mar; 16(3):293-306. PubMed ID: 20048751
[TBL] [Abstract][Full Text] [Related]
7. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.
Lipina TV; Niwa M; Jaaro-Peled H; Fletcher PJ; Seeman P; Sawa A; Roder JC
Genes Brain Behav; 2010 Oct; 9(7):777-89. PubMed ID: 20618446
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia.
Guo X; Hamilton PJ; Reish NJ; Sweatt JD; Miller CA; Rumbaugh G
Neuropsychopharmacology; 2009 Jun; 34(7):1659-72. PubMed ID: 19145222
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
Pei JC; Hung WL; Lin BX; Shih MH; Lu LY; Luo DZ; Tai HC; Studer V; Min MY; Lai WS
J Psychopharmacol; 2019 Oct; 33(10):1288-1302. PubMed ID: 31294644
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice.
Shoji H; Toyama K; Takamiya Y; Wakana S; Gondo Y; Miyakawa T
BMC Res Notes; 2012 Feb; 5():108. PubMed ID: 22348257
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia.
Pletnikov MV; Ayhan Y; Nikolskaia O; Xu Y; Ovanesov MV; Huang H; Mori S; Moran TH; Ross CA
Mol Psychiatry; 2008 Feb; 13(2):173-86, 115. PubMed ID: 17848917
[TBL] [Abstract][Full Text] [Related]
12. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
Takagi S; Balu DT; Coyle JT
Schizophr Res; 2015 Mar; 162(1-3):216-21. PubMed ID: 25592804
[TBL] [Abstract][Full Text] [Related]
13. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice.
Lipina TV; Zai C; Hlousek D; Roder JC; Wong AH
J Neurosci; 2013 May; 33(18):7654-66. PubMed ID: 23637159
[TBL] [Abstract][Full Text] [Related]
14. Serine racemase binds to PICK1: potential relevance to schizophrenia.
Fujii K; Maeda K; Hikida T; Mustafa AK; Balkissoon R; Xia J; Yamada T; Ozeki Y; Kawahara R; Okawa M; Huganir RL; Ujike H; Snyder SH; Sawa A
Mol Psychiatry; 2006 Feb; 11(2):150-7. PubMed ID: 16314870
[TBL] [Abstract][Full Text] [Related]
15. Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction.
Jami SA; Cameron S; Wong JM; Daly ER; McAllister AK; Gray JA
J Neurophysiol; 2021 Jul; 126(1):11-27. PubMed ID: 34038186
[TBL] [Abstract][Full Text] [Related]
16. Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum.
Takagi S; Balu DT; Coyle JT
Brain Res; 2021 Jan; 1751():147202. PubMed ID: 33171153
[TBL] [Abstract][Full Text] [Related]
17. Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function.
Benneyworth MA; Basu AC; Coyle JT
Psychopharmacology (Berl); 2011 Jan; 213(1):143-53. PubMed ID: 20865248
[TBL] [Abstract][Full Text] [Related]
18. Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serine.
Hagiwara H; Iyo M; Hashimoto K
PLoS One; 2013; 8(4):e62438. PubMed ID: 23630632
[TBL] [Abstract][Full Text] [Related]
19. Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes.
Willi R; Weinmann O; Winter C; Klein J; Sohr R; Schnell L; Yee BK; Feldon J; Schwab ME
J Neurosci; 2010 Jan; 30(2):556-67. PubMed ID: 20071518
[TBL] [Abstract][Full Text] [Related]
20. GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
Suryavanshi PS; Ugale RR; Yilmazer-Hanke D; Stairs DJ; Dravid SM
Br J Pharmacol; 2014 Feb; 171(3):799-809. PubMed ID: 24236947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
